Abstract A079: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH): A successful precision medicine signal-seeking trial in patients (pts) with rare variants and refractory malignancies
Year: 2019
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Lyndsay N Harris, Robert J Gray, Barbara A Conley, Alice P Chen, Keith T Flaherty, Stanley R Hamilton, Paul M Williams, Chris Karlovich, David Patton, Shuli Li, Lisa M McShane, Larry V Rubinstein, Edith P Mitchell, James V Tricoli, Richard F Little, Carlos L Arteaga, Peter J O'Dwyer, NCI-MATCH team
Institutions: National Cancer Institute, Dana-Farber Cancer Institute, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, Frederick National Laboratory for Cancer Research, Thomas Jefferson University Hospital, The University of Texas Southwestern Medical Center, University of Pennsylvania
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2991771633